BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 19807331)

  • 1. Cost-effectiveness and HRQOL outcomes of divalproex sodium (Depakote) in bipolar disorder.
    Revicki DA
    Expert Rev Pharmacoecon Outcomes Res; 2004 Feb; 4(1):9-14. PubMed ID: 19807331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.
    Revicki DA; Hirschfeld RM; Ahearn EP; Weisler RH; Palmer C; Keck PE
    J Affect Disord; 2005 Jun; 86(2-3):183-93. PubMed ID: 15935238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoeconomic and health outcome comparison of lithium and divalproex in a VA geriatric nursing home population: influence of drug-related morbidity on total cost of treatment.
    Conney J; Kaston B
    Am J Manag Care; 1999 Feb; 5(2):197-204. PubMed ID: 10346515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of open acute mania treatment to blinded maintenance outcome in bipolar I disorder.
    McElroy SL; Bowden CL; Collins MA; Wozniak PJ; Keck PE; Calabrese JR
    J Affect Disord; 2008 Apr; 107(1-3):127-33. PubMed ID: 17888516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacoeconomic model of divalproex vs. lithium in the acute and prophylactic treatment of bipolar I disorder.
    Keck PE; Nabulsi AA; Taylor JL; Henke CJ; Chmiel JJ; Stanton SP; Bennett JA
    J Clin Psychiatry; 1996 May; 57(5):213-22. PubMed ID: 8626353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder.
    Goodwin FK
    J Clin Psychiatry; 2003; 64 Suppl 5():18-24. PubMed ID: 12720480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical antipsychotic augmentation of mood stabilizer therapy in bipolar disorder.
    Bowden CL
    J Clin Psychiatry; 2005; 66 Suppl 3():12-9. PubMed ID: 15762830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).
    Vieta E; Suppes T; Eggens I; Persson I; Paulsson B; Brecher M
    J Affect Disord; 2008 Aug; 109(3):251-63. PubMed ID: 18579216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000.
    Sachs GS; Printz DJ; Kahn DA; Carpenter D; Docherty JP
    Postgrad Med; 2000 Apr; Spec No():1-104. PubMed ID: 10895797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder.
    Kowatch RA; Suppes T; Carmody TJ; Bucci JP; Hume JH; Kromelis M; Emslie GJ; Weinberg WA; Rush AJ
    J Am Acad Child Adolesc Psychiatry; 2000 Jun; 39(6):713-20. PubMed ID: 10846305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials.
    Prescrire Int; 2005 Aug; 14(78):140-2. PubMed ID: 16106596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of bipolar mania with atypical antipsychotics.
    Chengappa KN; Suppes T; Berk M
    Expert Rev Neurother; 2004 Nov; 4(6 Suppl 2):S17-25. PubMed ID: 16279862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Report on efficacy of treatments for bipolar disorder.
    Gelenberg AJ; Hopkins HS
    Psychopharmacol Bull; 1993; 29(4):447-56. PubMed ID: 8084977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Budgetary impact of treating acute bipolar mania in hospitalized patients with quetiapine: an economic analysis of clinical trials.
    Caro JJ; Huybrechts KF; Xenakis JG; O'Brien JA; Rajagopalan K; Lee K
    Curr Med Res Opin; 2006 Nov; 22(11):2233-42. PubMed ID: 17076984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decision tree for the treatment of bipolar disorder.
    Sachs GS
    J Clin Psychiatry; 2003; 64 Suppl 8():35-40. PubMed ID: 12892540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divalproex sodium in the treatment of adults with bipolar disorder.
    Davis LL; Williams R; Cates M
    Expert Rev Neurother; 2004 May; 4(3):349-62. PubMed ID: 15853533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, placebo-controlled, multicenter study of divalproex sodium extended-release in the acute treatment of mania.
    Hirschfeld RM; Bowden CL; Vigna NV; Wozniak P; Collins M
    J Clin Psychiatry; 2010 Apr; 71(4):426-32. PubMed ID: 20361904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mood stabilization in the treatment of bipolar disorder: focus on quetiapine.
    Vieta E
    Hum Psychopharmacol; 2005 Jun; 20(4):225-36. PubMed ID: 15880391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-based utilities for bipolar disorder-related health states.
    Revicki DA; Hanlon J; Martin S; Gyulai L; Nassir Ghaemi S; Lynch F; Mannix S; Kleinman L
    J Affect Disord; 2005 Aug; 87(2-3):203-10. PubMed ID: 16005983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.